Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Customers can receive free parking at an airport by simply allowing others to rent out their vehicles, instead of leaving their cars idle in the airport cark park. ForestCar aim to help reduce harmful vehicle emission and are a part of a reforestation programme whereby a share of their revenue is invested in restoring global rainforests.
days to go:
Expired
investment:
£210,000
Fore Fitness Group (FFG) is a company that operates the easyGym and PACK45 brands in the fitness space. It operates 20 affordable but high-quality easyGym units across 3 countries. FFG plans to open gyms, boutique studios across the world and develop digital assets such as workout apps. It is developing two new products: an innovative workout app, and an effective & easy-to-use home fitness equipment machine. FFG believes that these steps will appeal to fitness enthusiasts both during and after the Covid-19 pandemic. FFG’s’ vision is to operate the largest fitness network in the world by 2030. The company will use the investment: 10% of it to patent, prototype and gather initial feedback for the home fitness equipment, 20% to build, market and ship the first orders for the home fitness equipment, 15% to market and establish momentum for the workout app, 15% to launch a premium version of the online fitness library, 20% for company costs such as rent and staffing, and the rest for investment opportunities that may present themselves and to seek new Master Franchise Agreements (MFAs) for different countries with eligible partners.
days to go:
Expired
investment:
£1,462,390
Their unique adiposet system dramatically improves the patient experience of breast reconstruction following breast cancer treatment, whilst improving clinical practice and reducing cost to NHS and private hospitals. Adiposet also has applications in many other therapeutic and cosmetic procedures.
days to go:
Expired
investment:
£446,380
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
Camptoo is a web application by which travellers can rent a motorhome straight from the owner. Its users can easily rent any of the available 3,000+ vehicles offered in fifteen countries. This company turned motorhome ownership into a revenue-making venture instead of an expensive hobby. More than 50,000 users have experienced travelling using Camptoo, and its number is growing year on year. It was part of the Google Launchpad accelerator program in 2015. Furthermore, in the Netherlands, it was awarded 'most promising startup' by Deloitte Technology Fast50 Jury in 2017, and in Europe, '16th fastest growing tech company' by TheNextWeb in 2018. With the proceeds, this company will further accelerate marketing campaigns in Australia and the UK and further optimize its current web application.
days to go:
Expired
investment:
£476,642
Please watch the video for more information
days to go:
Expired
investment:
£673,054
